Atria Investments Inc Has $523,000 Position in SPDR S&P Biotech ETF $XBI

Atria Investments Inc lessened its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 36.3% during the second quarter, Holdings Channel reports. The fund owned 6,311 shares of the exchange traded fund’s stock after selling 3,597 shares during the period. Atria Investments Inc’s holdings in SPDR S&P Biotech ETF were worth $523,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Investment Partners Asset Management Inc. boosted its position in SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after purchasing an additional 125 shares during the period. Compass Ion Advisors LLC grew its stake in SPDR S&P Biotech ETF by 3.9% in the 2nd quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock valued at $309,000 after buying an additional 140 shares during the last quarter. McAdam LLC raised its holdings in SPDR S&P Biotech ETF by 5.1% in the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock valued at $271,000 after acquiring an additional 159 shares during the period. First Heartland Consultants Inc. lifted its position in SPDR S&P Biotech ETF by 2.7% during the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock worth $514,000 after acquiring an additional 168 shares during the last quarter. Finally, Calton & Associates Inc. boosted its holdings in shares of SPDR S&P Biotech ETF by 3.2% during the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock worth $459,000 after acquiring an additional 175 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $108.96 on Monday. The firm has a market cap of $6.61 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The stock’s fifty day moving average price is $102.21 and its two-hundred day moving average price is $90.50. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $113.21.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.